Rockefeller Capital Management’s Zomedica Corp. ZOM Stock Holding History

Rockefeller Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,000	Closed	-$10K	–	2085
2023 Q1	$10K	Buy	49,000 +48,840	+30,525%	+$12K	﹤0.01%	1956
2022 Q4	$0	Hold	160	–	–	﹤0.01%	4440
2022 Q3	$0	Hold	160	–	–	﹤0.01%	4630
2022 Q2	$0	Buy	+160	New	+$41	﹤0.01%	4587

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Rockefeller Capital Management's ZOM Position: Q2 2023 in Review

Rockefeller Capital Management sold out of Zomedica Corp. (ZOM) in Q2 2023, closing a stake of 49,000 shares — an estimated $10K sold.

Rockefeller Capital Management first reported a position in ZOM in Q2 2022 and held it in 4 quarters. The position peaked at $10K in Q1 2023. 92 funds tracked by Wall St. Rank hold ZOM as of Q2 2023.

Rockefeller Capital Management reported no remaining Zomedica Corp. position as of Q2 2023 after selling out during the quarter.
Rockefeller Capital Management sold 49,000 Zomedica Corp. shares in Q2 2023, an estimated $10K.
Rockefeller Capital Management first reported a position in Zomedica Corp. in Q2 2022 and held it in 4 quarters.
Rockefeller Capital Management's Zomedica Corp. position peaked at $10K in Q1 2023.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.